Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Cell cycle progression protein 1 (CCPG1) is a vertebrate-specific ER membrane protein serving as a bispecific receptor for selective autophagy of the endoplasmic reticulum (ER-phagy)[1][2]. It contains a large ER luminal region (>500 amino acids) harboring multiple highly conserved cargo-interacting regions (CIRs) that enable CCPG1 to recognize and bind aggregation-prone and misfolded ER luminal proteins. Through these domains, CCPG1 directly interacts with ER-localized substrates (e.g., P3H4, 6xIAPP), and with autophagy-related proteins (such as LC3 and FIP200) on the cytoplasmic side, linking targeted cargo recognition to formation and delivery into autophagosomes. CCPG1 expression is upregulated by cellular ER stress and is essential for effective protein quality control, maintaining ER and cellular homeostasis under stress conditions. Loss or dysfunction of CCPG1 impairs selective ER-phagy, leading to accumulation of toxic ER proteins and contributing to various pathologies, including malignancies driven by defective protein degradation. CCPG1 is not currently a direct drug target, but its pathway is under active investigation for understanding and treating diseases of impaired proteostasis or selective autophagy[1][2].
Not established for drugs; however, CCPG1 enables cargo-selective ER-phagy by interacting via its cargo-interacting regions (CIRs) with ER luminal proteins and the autophagic membrane[1][2].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Cell cycle progression protein 1 (CCPG1).